Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion

International Journal of Tissue Reactions

Volumn 21, Issue 1, 1999, Pages 1-6

  Calvani, M ^a   Arrigoni Martelli, E ^a  

^a Sigma Tau SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVACECARNINE;

BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PERFUSION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; NEUROPROTECTION; NONHUMAN; REVIEW;

ACETYLCARNITINE; ANIMALS; BRAIN; BRAIN ISCHEMIA; CARNITINE; DOGS; OXIDATION-REDUCTION; RATS; REPERFUSION INJURY;

CANIS FAMILIARIS;

EID: 0032875579     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Pulsinelli W. Pathophysiology of acute ischemic stroke. Lancet, 339, 533, 1992.
2. Buchan A.M., Slivka A., Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res., 574, 171, 1992.
3. Hong S.C., Goto Y., Lanzino G., et al. Neuroprotection with calpain inhibitor in a model of focal cerebral ischemia. Stroke, 25, 663, 1994.
4. Wahl F., Alix M., Plotkine M., et al. Effect of riluzole on focal cerebral ischemia in rats. Eur. J. Pharmacol., 230, 209, 1993.
5. Sims N.R. Selective impairment of respiration in mitochondria isolated from brain subregions following transient forebrain ischemia in the rat. J. Neurochem., 56, 1836, 1991.
6. Crumrine R.C., La Manna J.C. Regional cerebral metabolites, blood flow, plasma volume, and mean transit time in total cerebral ischemia in the rat. J. Cereb. Blood Flow Metab., 11, 272, 1991.
7. Arai H., Passonneau J.V, Lust W.D. Energy metabolism in delayed neuronal death of CA1 neurons of the hippocampus following transient ischemia in the gerbil. Metabol. Brain Disease, 1, 263, 1986.
8. Katayama Y., Welsh F.A. Effect of dichloroacetate on regional energy metabolites and pyruvate dehydrogenase activity during ischemia and reperfusion in gerbil brain. J. Neurochem., 7, 752, 1987.
9. Siesjo B.K. Influence of acidosis on lipid peroxidation in brain tissue in vitro. J. Cereb. Blood Flow Metab., 5, 253, 1985.
10. Lundgren J., Zhang H., Agardh C.D., et al. Acidosis-induced brain damage: Are free radicals involved? J. Cereb. Blood Flow Metab., 11, 587, 1991.
11. Funahashi T., Floyd R.A., Carney J.M. Age effect on brain pH during ischemia/reperfusion and pH influence on peroxidation. Neurobiol. Aging, 15, 161, 1994.
12. Hillered L., Ernester L. Respiratory activity of isolated rat brain mitochondria following in vitro exposure to oxygen radicals. J. Cereb. Blood Flow Metab., 3, 207, 1983.
13. Abe K., Aoki M., Kawagoe I., et al. Ischemic delayed neuronal death: A mitochondrial hypothesis. Stroke, 26, 1478, 1995.
14. ++ efflux from liver mitochondria induced by a decrease in extramitochondrial pH. FEBS Lett., 119, 297, 1980.
15. Hoppel C. The physiological role of carnitine. In: Ferrari R., Di Mauro S., Sherwood G. (Eds.). "L-Carnitine and its Role in Medicine: From Function to Therapy". Academic Press Ltd., London, 1992, pp. 5-20.
16. Engel A.G. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: A new syndrome. Science, 2, 899, 1973.
17. Karpati G., Carpenter S., Engel A.G., et al. The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical, and pathophysiologic features. Neurology, 25, 16, 1975.
18. Roe C.R., Millington D.S., Hoppel C.L.. et al. L-carnitine enhances excretion of propionyl CoA as a propionyl carnitine in propionic aciduria. J. Clin. Invest., 73, 1785, 1984.
19. Karmazyn M. Ischemic and reperfusion injury in the heart: Cellular mechanisms and pharmacological interventions. Can. J. Physiol. Pharmacol., 69, 719, 1991.
20. Liedtke A.J., Molaparast-Saless F. Secondary carnitine deficiency in cardiac disease. In: Borum P.R. (Ed.). "Clinical Aspects of Human Carnitine Deficiency". Pergamon Press, New York, 1986, pp. 204-205.
21. Siliprandi N., Siliprandi D., Ciman M. Stimulation of oxidation, of mitochondrial fatty acids, and of acetate by acetylcarnitine. Biochem. J., 66, 777, 1965.
22. Forloni G., Angretti N., Sliroldo S. Neuroprotective activity of acetyl-L-carnitine: Studies in vitro. J. Neurosc. Res., 37, 92, 1994.
23. Bresolin N., Freddo L., Vergani L., Angelini C. Carnitine, carnitine-acyltransferase, and rat brain function. Exp. Neurol., 78, 285, 1982.
24. 11C) acetyl-L-carnitine into the rat brain: A PET study. Biochem. Biophys. Res. Comm., 231, 488, 1997.
25. Aureli T., Di Cocco M.E., Puccetti C., et al. Acetyl-L-carnitine modulates glucose metabolism and stimulates glycogen synthesis in the rat brain. Brain Res., 796, 75, 1998.
26. Burlina A.P., Serohen H., Debler E.A., Lajtha A. Uptake of acetyl-L- camitine in the brain. Neurochem. Res., 14, 489, 1989.
27. Borzeix M.G., Cahn R., Cahn G. Effect of ALC on early and late consequences of a transient forebrain ischemia in the rat. In: Agnoli A., Cahn J., Lassen N., Layeux R. (Eds.). "Senile Dementia. II Int. Symposium". John Libbey Eurotest, London, 1988, pp. 383-389.
28. Brint S., Jacewicz M., Kiesslin M., et al. Focal brain ischemia in rat. Methods of reproducible neocortical infarction using tandem occlusion of the distal middle cerebral, and ipsilateral common carotid arteries. J. Cereb. Blood Flow Metab., 8, 474, 1988.
29. Wahl F., Alix M., Plotkine M., et al. Neurological and behavioral outcome of focal cerebral ischemia in rats. Stroke, 23, 267, 1992.
30. Lolic M.M., Fiskum G., Rosenthal R.E. Neuroprotective effect of acetyl-L-carnitine after stroke in rats. Ann. Emerg. Med., 29, 758, 1997.
31. Lindsay S., Liu T.H., Xu J., et al. Roie of xanthine dehydrogenase and oxidase in focal cerebral ischemic injury to the rats. Am. J. Physiol., 261, 2051, 1991.
32. Fox G., Gallacher D., Shevde S., et al. Anatomic variations of the middle cerebral artery in Sprague Dawley rat. Stroke, 24, 2087, 1993.
33. Shuaib A., Waqaar T., Wishart T., et al. Acetyl-L-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult. Neurochem. Res., 20, 1021, 1995.
34. Clifton G.L., Taft W., Blair R.E., et al. Conditions for pharmacological evaluation in the gerbil model of forebrain ischemia. Stroke, 20, 1545, 1989.
35. Rosenthal R.E., Williams R., Bogaert Y.E., et al. Prevention of post-ischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke, 23, 1312, 1992.
36. Angelos M., Safar P., Reich H. External cardiopulmonary resuscitation preserves brain viability after prolonged cardiac arrest in dogs. Am. J. Emerg. Med., 9, 435, 1991.
37. Ibayashi S., Fujishima M., Sadoshima S., et al. Cerebral blood flow and tissue metabolism in experimental cerebral ischemia of spontaneously hypertensive rats with hyper-, normo-, and hypoglycemia. Stroke, 17, 261, 1985.
38. 1H-NMR spectroscopy. Brain Res., 643, 92, 1994.
39. Nishijma M.K., Koehler R.C., Hum P.D., et al. Post-ischemic recovery rate of cerebral ATP, phosphocreatine, pH, and evoked potentials. Am. J. Physiol., 257, 1860, 1989.
40. Siliprandi N., Di Lisa F., Tominello A. Biochemical derangement in ischemic myocardium: The role of carnitine. J. Ital. Cardiol., 14, 804, 1984.
41. Fiskum G., Rosenthal R.E. Neurological impairment, lipid alteration, and delayed mitochondrial injury following cardiac arrest and resuscitation. J. Cereb. Blood Flow Metab., 11, 5329, 1991.
42. Rosenthal R.E., Fiskum G. Brain mitochondrial function in cerebral ischemia and resuscitation. In: Schurr A. (Ed.). "Cerebral Ischemia and Resuscitation". CRC Press, New York, pp. 289-300.
43. Bogaert Y.E., Rosenthal R.E. Fiskum G. Postischemic inhibition of cerebral cortex pyruvate dehydrogenase. Free Rad. Biol. Med., 16, 811, 1994.
44. Liu Y., Rosenthal R.E., Starke-Reed P., Fiskum G. Inhibition of post cardiac arrest brain protein oxidation by acetyl-L-carnitine. Free Rad. Biol. Med., 15, 667, 1993.
45. Fariello R.G., Calabrese V. Prevention of ischemic induced increase of malonaldehide by acetylcarnitine. Ann. Neurol., 24, 154, 1988.